Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-10 08:10 am Purchase | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 4,280,516 10.522% | 1,687,577 (+65.08%) | View |
| 2022-06-10 10:14 am Sale | 13G | ALX Oncology Holdings Inc. ALXO | WELLINGTON MANAGEMENT GROUP LLP | 1,128,101 2.77% | -2,600,229 (-69.74%) | View |
| 2022-02-09 09:09 am Purchase | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 2,592,939 6.402% | 2,592,939 (New Position) | View |
| 2022-02-04 09:12 am Sale | 13G | ALX Oncology Holdings Inc. ALXO | WELLINGTON MANAGEMENT GROUP LLP | 3,728,330 9.21% | -476,797 (-11.34%) | View |
| 2021-09-10 08:54 am Purchase | 13G | ALX Oncology Holdings Inc. ALXO | WELLINGTON MANAGEMENT GROUP LLP | 4,205,127 10.42% | 4,205,127 (New Position) | View |
| 2021-06-15 12:19 pm Purchase | 13D | ALX Oncology Holdings Inc. ALXO | Logos Global Management LP | 3,156,981 7.9% | 76,080 (+2.47%) | View |
| 2020-10-01 10:01 am Purchase | 13D | ALX Oncology Holdings Inc. ALXO | venBio Global Strategic Fund II L.P. | 9,799,331 26.9% | 9,799,331 (New Position) | View |
| 2020-08-25 7:08 pm Purchase | 13D | ALX Oncology Holdings Inc. ALXO | Logos Global Management LP | 3,080,901 8.4% | 3,080,901 (New Position) | View |
| 2020-07-30 9:53 pm Purchase | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 4,720,990 12.9% | 4,720,990 (New Position) | View |
| 2020-07-29 4:35 pm Purchase | 13G | ALX Oncology Holdings Inc. ALXO | Vivo Capital IX, LLC | 4,034,522 11.1% | 4,034,522 (New Position) | View |